A fluorescent analysis of CD4+, CD8+ and CD20+ lymphocytes in breast cancer using fluorescently tagged antibodies and the AQUA image analysis system demonstrated an association of AQUA scores and pathologic complete response in a cohort of patients treated with neoadjuvant chemotherapy [34]. This evidence concerns the gene CD8A and breast carcinoma.